Skip to main content

CASE REPORT article

Front. Genet.
Sec. Genetics of Common and Rare Diseases
Volume 15 - 2024 | doi: 10.3389/fgene.2024.1410727
This article is part of the Research Topic Novel Approaches in Disease Mechanisms and Therapies for Muscular Dystrophies View all articles

Case report: A novel mutation of the CAPN3 gene in a Chinese family with limb girdle muscular dystrophy type 2A

Provisionally accepted
Ganqin Du Ganqin Du 1,2*Wanjun Feng Wanjun Feng 2Yanyan Cao Yanyan Cao 2Ruolin Ren Ruolin Ren 2Xiaohui Yang Xiaohui Yang 2Chunyan Cao Chunyan Cao 2Hongwei Jiang Hongwei Jiang 2
  • 1 Henan University of Science and Technology, Luoyang, China
  • 2 The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan Province, China

The final, formatted version of the article will be published soon.

    Limb girdle muscular dystrophy type 2A (LGMD R1 Calpain 3-Related,LGMD2A/R1), an autosomal recessive disorder, is characterized by progressive muscle weakness with a prominent presentation in the proximal limb girdle muscles.LGMD2A/R1 which caused by variants in calcium-activated neutral proteinase 3 (CAPN3) is the most common. The present study aimed at identifying the clinically significant variants in a Chinese family with LGMD2A/R1 and exploring the genotypephenotype correlations. Clinical symptom, laboratory findings and physical examination were obtained. Genomic DNA was extracted from the peripheral blood samples of this family. Whole-exome sequencing (WES) and sanger sequencing were used to explore and validate the pathogenic genes. In this study, proband and his sister who had two identical mutations in the CAPN3 gene sequence exhibited diverse clinical features including disease onset and progression. The mutation c.2120 A>G (p. D707G) is pathogenic which has been reported in the Human Gene Mutation Database (HGMD) and ClinVar database. c.1783-72 C>G may be a novel pathogenic mutation ofLGMD2A/R1 based on the ACMG (the American College of Medical Genetics guidelines), which widens the gene variant pool in CAPN3, improve diagnosis and genetic counselling.

    Keywords: limb girdle muscular dystrophy type 2A, CAPN3, progressive muscle weakness and wasting, Gene splicing, Autosomal recessive disorder

    Received: 07 May 2024; Accepted: 26 Jul 2024.

    Copyright: © 2024 Du, Feng, Cao, Ren, Yang, Cao and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Ganqin Du, Henan University of Science and Technology, Luoyang, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.